This report studies the global market size of Targeted RNA Sequencing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Targeted RNA Sequencing in these regions. This research report categorizes the global Targeted RNA Sequencing market by top players/brands, region, type and end user. This report also studies the global Targeted RNA Sequencing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types. Market competition is not intense. Thermo Fisher, Illumina, Roche?Holdings, BGI, Eurofins, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The global Targeted RNA Sequencing market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Targeted RNA Sequencing market based on company, product type, end user and key regions. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Thermo Fisher Illumina Roche?Holdings BGI Eurofins LabCorp Berry Genomics Macrogen GENEWIZ Market size by Product enrichment approaches amplicon-based approaches Market size by End User Research?Institutes Hospitals?&?Clinics Biotechnology?Company Diagnostic Lab Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Targeted RNA Sequencing market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025. To understand the structure of Targeted RNA Sequencing market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Targeted RNA Sequencing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Targeted RNA Sequencing submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Targeted RNA Sequencing are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Targeted RNA Sequencing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Targeted RNA Sequencing Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Targeted RNA Sequencing Market Size Growth Rate by Product 1.4.2 enrichment approaches 1.4.3 amplicon-based approaches 1.5 Market by End User 1.5.1 Global Targeted RNA Sequencing Mar
